This site is intended for healthcare professionals only
LoginRegister

Obstetrics and Gynaecology Dialogues

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

USFDA approves Novartis Kisqali to reduce risk of recurrence in people with HR+/HER2- early breast...

Basel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase...
View All

Latest News and Guidelines

Combination of Metronidazole and Cefazolin Halves Surgical Site Infection Rates in Gynecologic Surgery, Study Shows

Combination of Metronidazole and Cefazolin Halves Surgical Site Infection Rates in Gynecologic...

Clinical hypnosis vs. cognitive behavioral therapy: Whats better for managing hot flashes?

Clinical hypnosis vs. cognitive behavioral therapy: What's better for managing hot flashes?

Air pollution linked to higher risk of infertility in men, States study

Air pollution linked to higher risk of infertility in men, States study

Menstrual cycle may influence spread of mutant cells in mammary tissue, suggests research

Menstrual cycle may influence spread of mutant cells in mammary tissue, suggests research

Heart Attack

Timing of nocturnal hot flashes may affect risk of heart disease for perimenopausal women: Study

Breast arterial calcification could be warning sign of heart disease, reports research

Breast arterial calcification could be warning sign of heart disease, reports research

View All
X